Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to $327335.4.

  • ProQR Therapeutics' Other Non Operating Income fell 3644.77% to $327335.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 2280.53%. This contributed to the annual value of -$3.3 million for FY2021, which is 2221.01% up from last year.
  • ProQR Therapeutics' Other Non Operating Income amounted to $327335.4 in Q3 2025, which was down 3644.77% from $217336.2 recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics' Other Non Operating Income ranged from a high of $1.2 million in Q2 2022 and a low of -$3.0 million during Q2 2021
  • For the 5-year period, ProQR Therapeutics' Other Non Operating Income averaged around $32400.2, with its median value being $361246.9 (2025).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first crashed by 16103.3% in 2022, then skyrocketed by 19079.41% in 2024.
  • ProQR Therapeutics' Other Non Operating Income (Quarter) stood at -$340903.4 in 2021, then skyrocketed by 277.16% to $603956.4 in 2022, then plummeted by 34.57% to $395158.3 in 2023, then surged by 30.34% to $515065.0 in 2024, then tumbled by 36.45% to $327335.4 in 2025.
  • Its Other Non Operating Income stands at $327335.4 for Q3 2025, versus $217336.2 for Q2 2025 and $478607.4 for Q1 2025.